Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ACETYLCYSTEINE vs ACLARUBICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ACETYLCYSTEINE vs ACLARUBICIN: Safety Overview

Metric ACETYLCYSTEINE ACLARUBICIN
Total FAERS Reports 2,411 314
Deaths Reported 421 60
Death Rate 17.5% 19.1%
Hospitalizations 1,199 73
Average Patient Age 51.9 yrs 51.1 yrs
% Female Patients 54.2% 47.2%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Fresenius Kabi USA, LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A